Mankind Pharma IPO- Issue sails through on Day 3, oversubscribed at 2
时间:2024-06-26 10:26:27 阅读(143)
Mankind Pharma IPO opened for subscription on 25 April and the issue has been fully subscribed at 2.13 times on day 3, with total bids of 5.98 crore shares for the 2.8 crore shares offered. Qualified institutional buyers (QIBs) subscribed for 573% of their reserved portion, demonstrating high interest in the issue. The portion for retail investors remains undersubscribed as investors bid only 0.36 times of the shares reserved for RIIs. The NII portion garnered 147% bids so far. The IPO closes for subscription today.
Mankind Pharma shares’ GMP fell to Rs 30 on Thursday, compared to Rs 92 per equity share on Monday. The GMP indicated the shares are valued 2.78% over the upper end of the share price on offer. The price band for its public issue at Rs 1,026-1,080 per equity share of face value Re 1 each. At the upper end of the price band, the company’s promoters and shareholders seek to raise Rs 4,326.35 crore from the IPO.
“At the upper price band of Rs 1,080, MPL is available at a P/E of 30x (FY22), which appears reasonably priced compared to peers. Considering under-penetration of healthcare services and lower consumer expenditure in healthcare in India, MPL’s focus on chronic therapeutic areas, emphasis on increasing penetration in metro and Class I cities, growth in consumer healthcare business, good financial performance and strong distribution network, we assign a “Subscribe” rating on a long term basis,” said Geojit Financial Services, recommending investors subscribe to the issue.
猜你喜欢
- Sebi cancels registration of Emkay Commotrade in NSEL case
- FII, DII data- FPIs bought shares worth Rs 1088 cr, DIIs sold shares worth Rs 333 cr on July 25, Tuesday
- Air India’s connection to Ayodhya- Direct flights linking Ayodhya to Bengaluru and Kolkata will be operational from THIS day – Details Inside
- Ajanta Pharma stock jumps nearly 9% on strong Q1 results; Should you buy, sell or hold Ajanta Pharma shares-
- Annuities- Blueprint for financial stability & fortification
- F&O Outlook- Nifty may fall towards 16500 in near term; support in 16300-16200 range, resistance at 17000
- Alibaba shares slide 4 percent after former CEO quits cloud unit
- SBFC Finance IPO Listing- Shares have bumper debut on bourses, list at 44% premium
- As long as Nifty 50 above 18,600, positive sentiment to continue; Granules India, GAIL among stocks to buy